Brain tumour treatment: emerging therapies
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Brain tumour treatment: emerging therapies. This is an external device with anti-mitotic properties. Fully referenced neurology checklist.
Tumour treating fields (TTFields)
- This is an external device with anti-mitotic properties
- It is used together with chemotherapy
Retroviral replicating vector-mediated gene therapies
Locked: subscribe to see this section.
Salinomycin
Locked: subscribe to see this section.
Emerging vaccines
Locked: subscribe to see this section.
Other emerging therapies
Locked: subscribe to see this section.
References
- Wright J, Chugh J, Wright CH, et al. Laser interstitial thermal therapy followed by minimal-access transsulcal resection for the treatment of large and difficult to access brain tumors. Neurosurg Focus 2016; 41:E14.
- Hiraoka K, Inagaki A, Kato Y, et al. Retroviral replicating vector-mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity. Neuro Oncol 2017; doi: 10.1093/neuonc/nox038 (Epub ahead of print).
- Huang TT, Parab S, Burnett R, et al. Intravenous administration of retroviral replicating vector, Toca 511, demonstrates therapeutic efficacy in orthotopic immune-competent mouse glioma model. Hum Gene Ther 2015; 26:82-93.
- Magrath JW, Kim Y. Salinomycin's potential to eliminate glioblastoma stem cells and treat glioblastoma multiforme (Review). Int J Oncol 2017; 51:753-759.
- Gersey ZC, Rodriguez GA, Barbarite E, et al. Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species. BMC Cancer 2017; 17:99.
- And 7 more. Subscribe to see the full list
